News from accera, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 11, 2013, 10:17 ET

Accera, Inc. to Moderate Symposium on Metabolic Dysregulation in Alzheimer's Disease During the 6th Annual Clinical Trials Conference on Alzheimer's Disease (CTAD)

 Accera, Inc., a privately-held, commercial-stage healthcare company focused on the discovery and development of innovative clinical...

Oct 28, 2013, 10:17 ET
Apr 09, 2013, 10:17 ET

Accera and University of Miami Announce Collaboration to Study Axona® for Cognitive Impairment in Patients with Multiple Sclerosis

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical...

Nov 26, 2012, 10:17 ET

Accera Announces Initiation of Clinical Trial for AC-1204

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical...

Oct 24, 2012, 10:17 ET

Accera, Inc. Expands Senior Management Team to Advance Clinical Studies & Commercialization for Axona®

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical...

Sep 26, 2012, 10:17 ET

Accera, Inc. to Support the Alzheimer's Foundation of America's (AFA) National Memory Screening Day (NMSD)

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications...

Sep 13, 2012, 10:17 ET

Accera, Inc. to Present at the BioPharm America™ 2012 Partnering Conference in Boston, MA

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications...

Jul 18, 2012, 14:03 ET

Nestle Health Science takes stake in Accera, Inc. to Advance Potential of Axona®

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications...

Mar 18, 2012, 13:00 ET

Accera, Inc. Announces Data Presentation at the Annual Meeting of the American Association for Geriatric Psychiatry (AAGP) 2012

BROOMFIELD, Colo., March 18, 2012 /PRNewswire/ -- Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery...

Jan 03, 2012, 11:27 ET

Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative therapeutics to...

Oct 24, 2011, 10:17 ET

Accera, Inc. Donates $50,000 to the Alzheimer's Foundation of America for National Memory Screening Day

Accera, Inc., a biotech company specializing in cognitive health, announced today the company has donated $50,000 to the Alzheimer's Foundation of...

Oct 17, 2011, 10:17 ET

Genetic Profile Identified for Alzheimer's Patients Showing Heightened Response to Accera's Breakthrough Product Axona®

Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer’s...

Oct 05, 2010, 10:17 ET

Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease

Accera, Inc., a medical research and development company delivering breakthrough therapies for serious diseases such as Alzheimer's disease (AD),...

Mar 09, 2010, 11:02 ET

New Evidence Further Validates Ketone Body Therapy as an Effective Approach in Managing Alzheimer's Disease

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that...

Dec 01, 2009, 11:51 ET
A F ACCERA AXONA PRESCRIPTION THERAPY ACCERA AXONA PRESCRIPTION THERAPY

Axona is a prescription therapy showing positive results in Alzheimer's patients. (PRNewsFoto/Accera, Inc.)[TK]
 BROOMFIELD, CO UNITED STATES
 11/23/2009

Video: Tips for Caregivers and a New Therapy Offers Hope in the Fight Against Alzheimer's

November is Alzheimer's Awareness Month. Every 70 seconds someone in the United States develops Alzheimer's disease, and the number of cases is...

Nov 17, 2009, 13:47 ET
A F ACCERA DONATES TO ALZHEIMERS FOUNDATION OF AMERICA ACCERA DONATES TO ALZHEIMERS FOUNDATION OF AMERICA

Alzheimer's Foundation of America Receives Donation from Accera, Inc. (PRNewsFoto/Accera, Inc.)[AH]
 BROOMFIELD, CO UNITED STATES
 11/17/2009

Accera, Inc. Announces Culmination of Lost & Found Campaign: Company Donates $25,000 to the Alzheimer's Foundation of America for National Memory Screening Day

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced today the culmination of...

Nov 11, 2009, 12:35 ET

Accera, Inc. To Present at Lazard Capital Markets 6th Annual Healthcare Conference

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced today that it will present at...

Sep 18, 2009, 16:24 ET

Accera, Inc. to Present at UBS Global Life Sciences Conference

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced today that it will present at...

Aug 12, 2009, 11:32 ET

Accera Announces Peer-Reviewed Publication of the Results of its 90-Day Clinical Study of AC-1202 (Axona(TM) ) in Mild to Moderate Alzheimer's Disease

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) disorders, announced today...

Aug 11, 2009, 10:47 ET

Accera, Inc. to Support the Alzheimer's Foundation of America's National Memory Screening Day Through On-line Awareness Effort

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced today the launch of...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge